Carnitine Cholate Acetate Composition for Psoriasis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for psoriasis, such as steroids and tar, often have adverse effects and are ineffective for disorders like vitiligo and rosacea, and existing compositions, like French patent 2,850,276, fail to address psoriasis effectively.
Innovation Solution
A pharmaceutical composition combining carnitine, sodium cholate, sodium acetate, and optionally silver, which acts synergistically to provide an anti-exudative effect and accelerate wound healing, with the surfactant aiding medicament penetration and having lipid-dissolving activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If corticosteroids are used to treat psoriasis, then the effectiveness in reducing inflammation is improved, but adverse effects increase
Solution Approach 1:
The patent combines multiple active ingredients (carnitine, sodium cholate, sodium acetate, and optionally silver) into a single pharmaceutical composition. This combination approach replaces monotherapy with corticosteroids, aiming to achieve anti-inflammatory effects while avoiding the adverse effects associated with steroid use. The synergistic interaction between components is intended to provide effective psoriasis treatment with a safer profile.
Solution Approach 2:
The invention uses a composite pharmaceutical formulation containing four distinct components with different mechanisms of action. Carnitine provides metabolic support, sodium cholate acts as a surfactant and anti-inflammatory agent, sodium acetate contributes to the chemical environment, and silver provides antimicrobial properties. This composite material approach allows the treatment to address multiple aspects of psoriasis pathology simultaneously without relying on corticosteroids.
2Reliability
If tar is used to treat psoriasis, then the therapeutic effect is achieved, but irritant action increases
Solution Approach 1:
The patent fundamentally changes the chemical parameters of the treatment by replacing tar (a complex mixture of polycyclic aromatic hydrocarbons) with a formulation based on carnitine, sodium cholate, and sodium acetate. This parameter change maintains therapeutic effectiveness through alternative mechanisms while eliminating the irritant properties inherent to tar. The new composition operates through metabolic modulation and gentle surfactant action rather than the harsh keratoplastic effects of tar.
3Reliability
If French patent 2,850,276 composition is used, then treatment of dermatitis is achieved, but effectiveness for psoriasis is insufficient
Solution Approach 1:
The patent enhances the versatility of the base composition (from French patent 2,850,276) by adding carnitine and optimizing the combination of ingredients. The resulting formulation maintains effectiveness for dermatitis while gaining the capability to treat psoriasis, vitiligo, and rosacea. This multi-functionality is achieved through the synergistic combination of ingredients that can address diverse pathological mechanisms including inflammation, metabolic dysfunction, and pigmentation disorders.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively treats psoriasis by enhancing subcutaneous surfactant concentrations and promoting wound healing with reduced exudate, offering a superior therapeutic effect compared to individual ingredients.
Implementation Method 1
The inclusion in the combination of the invention of a steroidal surfactant known to have a lipid-dissolving activity
Implementation Method 2
The combination of the invention acts as a light compression bandage with an anti-exudative effect that accelerates wound healing
Data Source
AI summary
Disclosed is a composition comprising: a) carnitine, b) sodium cholate, c) sodium acetate, and optionally d) silver, for use in the treatment of psoriasis, vitiligo and rosacea.